Schedule 13G ownership disclosure
SUTRO BIOPHARMA INC
Security class unavailable · CUSIP: 869367102
Event date: 2023-09-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,549,320
- Percent of class
- 5.8600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-005066
- Form type
- SC 13G
- Filer
- ADAGE CAPITAL PARTNERS GP, L.L.C.
- CIK
- CIK 1165408
- Filed
- Oct 10, 2023
- Reporting period
- Sep 28, 2023
- Description
- Schedule 13G beneficial ownership